Global VC firm Big Idea Ventures (BIV) has unveiled the eight Singaporean startups selected for its New Protein accelerator programme.

This cohort comprises 15 early-stage ventures, of which seven are from New York.

The programme runs for five months and invests up to US$200,000 each in startups.

As per its website, a follow-on investment of US$3.5 million will also be made in the top 20 per cent companies that successfully complete the programme.

Non-financial support includes mentorship and connections with industry experts that can help scale the startup’s products.

“This group of startups has been incredible to work with in the New Protein Fund,” said Andrew D. Ive, founder of Big Idea Ventures. “All of these companies are addressing real-world challenges and represent some of the most promising innovations in the food and agriculture sectors.”

BIV’s New Protein Fund, a US$50-million fund, is dedicated to seed and early-stage investments in plant-based and cell-based food, ingredient and technology companies.

Also Read: Bühler invests in Big Idea Ventures’s New Protein Fund; to invest in up to 100 plant- and cell-based firms

Here is snapshot of the eight Singaporean startups:

Angie’s Tempeh: Tempeh fermentation technology to create protein-rich foods.

Animal Alternative Technologies: Cell-based meat services including bioreactors and software.

[Stealth Mode]: B2B ingredients company developing sustainable alternatives to tropical oils and animal fats.

GreenGourmet Foods: Plant-based dairy.

Haofood: Alternative chicken protein from peanut focused on the Asian market.

MAD Foods: Plant-based beverage.

Hybrid Accelerator (participants in both Singapore and New York)

Wellme: Plant-based yogurt.

Meat. The End: Production technique to replicate meat-like mouthfeel and taste.

Join our e27 Telegram groupFB community, or like the e27 Facebook page

Image Credit: Big Idea Ventures

The post A sneak peek into 8 Singapore startups joining Big Idea Ventures’s New Protein programme appeared first on e27.

content first appear on e27

Leave a Reply

Your email address will not be published. Required fields are marked *